Matthew Stone
Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 9 | 2026 | 682 | 3.310 |
Why?
| | Cardiac Surgical Procedures | 12 | 2025 | 611 | 3.050 |
Why?
| | Fontan Procedure | 8 | 2026 | 200 | 2.740 |
Why?
| | Heart Defects, Congenital | 10 | 2026 | 923 | 2.510 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2022 | 44 | 1.800 |
Why?
| | Blood Group Incompatibility | 2 | 2025 | 21 | 1.740 |
Why?
| | ABO Blood-Group System | 2 | 2025 | 56 | 1.680 |
Why?
| | Ventricular Function, Left | 8 | 2024 | 541 | 1.530 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2024 | 391 | 1.440 |
Why?
| | Ventricular Outflow Obstruction | 2 | 2022 | 38 | 1.440 |
Why?
| | Computed Tomography Angiography | 2 | 2023 | 151 | 1.390 |
Why?
| | Perfusion | 4 | 2025 | 255 | 1.390 |
Why?
| | Aortic Diseases | 3 | 2022 | 125 | 1.360 |
Why?
| | Patient Selection | 2 | 2026 | 728 | 1.360 |
Why?
| | Double Outlet Right Ventricle | 2 | 2022 | 9 | 1.320 |
Why?
| | Abnormalities, Multiple | 2 | 2025 | 195 | 1.300 |
Why?
| | Predictive Value of Tests | 4 | 2024 | 2113 | 1.230 |
Why?
| | Heart Ventricles | 7 | 2026 | 762 | 1.180 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 255 | 1.170 |
Why?
| | Hypoplastic Left Heart Syndrome | 4 | 2024 | 119 | 1.110 |
Why?
| | Hemodynamics | 6 | 2025 | 1114 | 1.010 |
Why?
| | Myocardial Contraction | 3 | 2025 | 292 | 1.000 |
Why?
| | Pulmonary Atresia | 2 | 2025 | 23 | 0.940 |
Why?
| | Cigarette Smoking | 2 | 2025 | 103 | 0.930 |
Why?
| | Postoperative Complications | 9 | 2025 | 3034 | 0.880 |
Why?
| | Sphingosine | 1 | 2025 | 46 | 0.850 |
Why?
| | Lung Transplantation | 3 | 2017 | 326 | 0.840 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2025 | 49 | 0.840 |
Why?
| | Infant | 15 | 2025 | 10114 | 0.840 |
Why?
| | Lysophospholipids | 1 | 2025 | 80 | 0.830 |
Why?
| | Reperfusion Injury | 3 | 2017 | 300 | 0.820 |
Why?
| | Mitochondria, Heart | 1 | 2025 | 107 | 0.810 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2025 | 140 | 0.810 |
Why?
| | Pulmonary Valve | 1 | 2025 | 100 | 0.770 |
Why?
| | Allografts | 1 | 2024 | 151 | 0.770 |
Why?
| | Central Venous Catheters | 2 | 2022 | 53 | 0.760 |
Why?
| | Aortic Coarctation | 1 | 2023 | 76 | 0.750 |
Why?
| | Coronary Circulation | 2 | 2022 | 134 | 0.750 |
Why?
| | Child | 24 | 2025 | 22693 | 0.740 |
Why?
| | Tissue and Organ Procurement | 2 | 2025 | 305 | 0.740 |
Why?
| | Fibroma | 1 | 2022 | 21 | 0.720 |
Why?
| | Atrioventricular Block | 1 | 2022 | 44 | 0.710 |
Why?
| | Heart Neoplasms | 1 | 2022 | 56 | 0.700 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 121 | 0.700 |
Why?
| | Aorta, Thoracic | 2 | 2023 | 284 | 0.690 |
Why?
| | Surgical Procedures, Operative | 3 | 2013 | 307 | 0.680 |
Why?
| | Infant, Newborn | 13 | 2025 | 6460 | 0.670 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.660 |
Why?
| | Child, Preschool | 14 | 2025 | 11913 | 0.660 |
Why?
| | Graft Rejection | 1 | 2024 | 516 | 0.650 |
Why?
| | Coronary Vessels | 1 | 2022 | 245 | 0.640 |
Why?
| | Coronary Angiography | 1 | 2022 | 325 | 0.640 |
Why?
| | Echocardiography | 1 | 2023 | 645 | 0.630 |
Why?
| | Retrospective Studies | 17 | 2025 | 17438 | 0.630 |
Why?
| | Humans | 61 | 2026 | 146342 | 0.620 |
Why?
| | Treatment Outcome | 17 | 2025 | 11821 | 0.620 |
Why?
| | Male | 38 | 2025 | 73396 | 0.590 |
Why?
| | Vena Cava, Inferior | 2 | 2024 | 80 | 0.590 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 349 | 0.580 |
Why?
| | Vascular Stiffness | 2 | 2020 | 488 | 0.560 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 32 | 0.560 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2018 | 27 | 0.540 |
Why?
| | Waiting Lists | 3 | 2025 | 251 | 0.530 |
Why?
| | Septal Occluder Device | 1 | 2018 | 37 | 0.530 |
Why?
| | Nicardipine | 1 | 2017 | 6 | 0.530 |
Why?
| | Laparoscopy | 2 | 2012 | 487 | 0.490 |
Why?
| | Shock | 1 | 2017 | 101 | 0.490 |
Why?
| | Calcium Channel Blockers | 1 | 2017 | 165 | 0.480 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 571 | 0.480 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2015 | 24 | 0.460 |
Why?
| | Female | 33 | 2025 | 79499 | 0.440 |
Why?
| | Extracellular Vesicles | 1 | 2017 | 176 | 0.430 |
Why?
| | Aortic Valve | 3 | 2023 | 360 | 0.430 |
Why?
| | Time Factors | 9 | 2025 | 7109 | 0.430 |
Why?
| | Health Resources | 2 | 2013 | 131 | 0.430 |
Why?
| | Smoking Cessation | 3 | 2025 | 442 | 0.430 |
Why?
| | Pneumothorax | 1 | 2015 | 54 | 0.420 |
Why?
| | Aorta | 5 | 2024 | 440 | 0.420 |
Why?
| | Lung | 3 | 2017 | 4122 | 0.420 |
Why?
| | Respiration, Artificial | 1 | 2019 | 711 | 0.420 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 174 | 0.400 |
Why?
| | Bronchoscopy | 1 | 2015 | 227 | 0.400 |
Why?
| | Catheters, Indwelling | 1 | 2013 | 94 | 0.370 |
Why?
| | Norwood Procedures | 2 | 2024 | 33 | 0.370 |
Why?
| | Heart Failure | 2 | 2024 | 2329 | 0.360 |
Why?
| | Specialties, Surgical | 1 | 2013 | 88 | 0.360 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2012 | 4 | 0.360 |
Why?
| | Coronary Sinus | 1 | 2012 | 9 | 0.350 |
Why?
| | Ethics, Medical | 1 | 2012 | 90 | 0.350 |
Why?
| | Pulmonary Artery | 4 | 2024 | 1116 | 0.350 |
Why?
| | Hospital Mortality | 3 | 2013 | 1051 | 0.350 |
Why?
| | Peritoneal Dialysis | 1 | 2013 | 100 | 0.350 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 29 | 0.340 |
Why?
| | Pericardium | 1 | 2012 | 59 | 0.340 |
Why?
| | Cardiopulmonary Bypass | 2 | 2025 | 217 | 0.340 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 64 | 0.340 |
Why?
| | Follow-Up Studies | 5 | 2025 | 5439 | 0.330 |
Why?
| | Renal Insufficiency | 1 | 2013 | 173 | 0.330 |
Why?
| | Tobacco Products | 2 | 2022 | 90 | 0.320 |
Why?
| | Suture Techniques | 1 | 2011 | 138 | 0.320 |
Why?
| | Diagnostic Errors | 1 | 2012 | 178 | 0.310 |
Why?
| | Adolescent | 10 | 2025 | 22557 | 0.310 |
Why?
| | Risk Factors | 9 | 2024 | 10921 | 0.310 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2012 | 197 | 0.310 |
Why?
| | Tricuspid Valve | 2 | 2025 | 42 | 0.300 |
Why?
| | Insurance, Health | 1 | 2013 | 318 | 0.300 |
Why?
| | Tetralogy of Fallot | 2 | 2020 | 76 | 0.290 |
Why?
| | Biomechanical Phenomena | 2 | 2024 | 874 | 0.280 |
Why?
| | Hypertension | 1 | 2017 | 1272 | 0.280 |
Why?
| | Magnetic Resonance Imaging, Cine | 4 | 2024 | 214 | 0.280 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 351 | 0.260 |
Why?
| | Incidence | 5 | 2022 | 2936 | 0.260 |
Why?
| | Age Factors | 3 | 2024 | 3347 | 0.250 |
Why?
| | Sex Factors | 1 | 2013 | 2107 | 0.250 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 6034 | 0.250 |
Why?
| | Smokers | 2 | 2025 | 139 | 0.250 |
Why?
| | Principal Component Analysis | 2 | 2024 | 192 | 0.240 |
Why?
| | Young Adult | 6 | 2025 | 14330 | 0.230 |
Why?
| | Socioeconomic Factors | 2 | 2025 | 1327 | 0.230 |
Why?
| | Heart | 2 | 2020 | 626 | 0.220 |
Why?
| | United States | 7 | 2025 | 16136 | 0.220 |
Why?
| | Pediatrics | 1 | 2013 | 1124 | 0.220 |
Why?
| | Product Labeling | 2 | 2022 | 12 | 0.220 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2025 | 28 | 0.210 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 45 | 0.210 |
Why?
| | Adenocarcinoma | 1 | 2012 | 927 | 0.210 |
Why?
| | Ventricular Function, Right | 2 | 2024 | 300 | 0.210 |
Why?
| | Scimitar Syndrome | 1 | 2024 | 10 | 0.210 |
Why?
| | Syndrome | 1 | 2025 | 380 | 0.200 |
Why?
| | Jugular Veins | 2 | 2022 | 41 | 0.200 |
Why?
| | Electronic Nicotine Delivery Systems | 2 | 2025 | 112 | 0.200 |
Why?
| | Vaping | 1 | 2025 | 81 | 0.200 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 117 | 0.190 |
Why?
| | Area Under Curve | 1 | 2024 | 335 | 0.190 |
Why?
| | Forecasting | 1 | 2025 | 388 | 0.190 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 39 | 0.190 |
Why?
| | Hospital Charges | 2 | 2013 | 45 | 0.190 |
Why?
| | Models, Cardiovascular | 2 | 2024 | 194 | 0.190 |
Why?
| | Vascular Resistance | 1 | 2024 | 365 | 0.190 |
Why?
| | Sternotomy | 1 | 2022 | 25 | 0.190 |
Why?
| | Calcinosis | 2 | 2023 | 231 | 0.180 |
Why?
| | Survival Rate | 2 | 2025 | 2092 | 0.180 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4580 | 0.180 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.170 |
Why?
| | Graft Survival | 1 | 2024 | 523 | 0.170 |
Why?
| | Fetal Diseases | 1 | 2023 | 192 | 0.170 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3416 | 0.170 |
Why?
| | Trachea | 2 | 2021 | 253 | 0.160 |
Why?
| | Mice | 5 | 2025 | 18297 | 0.160 |
Why?
| | Warm Ischemia | 2 | 2017 | 35 | 0.150 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2024 | 370 | 0.150 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 481 | 0.150 |
Why?
| | Stents | 1 | 2024 | 554 | 0.150 |
Why?
| | Proteome | 1 | 2024 | 520 | 0.150 |
Why?
| | Animals | 8 | 2025 | 38107 | 0.150 |
Why?
| | Cannula | 1 | 2018 | 30 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2024 | 3647 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2024 | 844 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1133 | 0.130 |
Why?
| | Transcriptome | 1 | 2025 | 1068 | 0.130 |
Why?
| | Prevalence | 1 | 2025 | 2861 | 0.130 |
Why?
| | Coronary Artery Disease | 1 | 2024 | 751 | 0.130 |
Why?
| | Smoking | 2 | 2022 | 1486 | 0.130 |
Why?
| | Umbilical Cord | 1 | 2017 | 92 | 0.130 |
Why?
| | Length of Stay | 2 | 2013 | 1358 | 0.120 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 931 | 0.120 |
Why?
| | Heart-Assist Devices | 2 | 2012 | 572 | 0.120 |
Why?
| | Extracorporeal Circulation | 1 | 2015 | 15 | 0.120 |
Why?
| | Biomarkers | 2 | 2024 | 4340 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3206 | 0.120 |
Why?
| | Research Design | 1 | 2020 | 1143 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1707 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2018 | 2070 | 0.100 |
Why?
| | Middle Aged | 9 | 2025 | 36619 | 0.100 |
Why?
| | Risk Assessment | 3 | 2019 | 3712 | 0.100 |
Why?
| | Radiation Dosage | 1 | 2015 | 193 | 0.100 |
Why?
| | Quality of Life | 1 | 2026 | 3200 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5899 | 0.100 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2599 | 0.100 |
Why?
| | Hospitals, Teaching | 1 | 2013 | 121 | 0.090 |
Why?
| | Rural Health | 1 | 2013 | 87 | 0.090 |
Why?
| | Aged | 7 | 2025 | 26432 | 0.090 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 59 | 0.090 |
Why?
| | Thymus Gland | 2 | 2024 | 310 | 0.090 |
Why?
| | Hospitals, Urban | 1 | 2013 | 140 | 0.090 |
Why?
| | Catheterization | 1 | 2013 | 179 | 0.090 |
Why?
| | Adult | 7 | 2025 | 41087 | 0.090 |
Why?
| | Risk Adjustment | 1 | 2013 | 86 | 0.090 |
Why?
| | Income | 1 | 2013 | 206 | 0.090 |
Why?
| | Intraoperative Complications | 1 | 2013 | 157 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2013 | 134 | 0.090 |
Why?
| | Cohort Studies | 4 | 2025 | 6077 | 0.090 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 63 | 0.090 |
Why?
| | Cryosurgery | 1 | 2012 | 46 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 96 | 0.090 |
Why?
| | Insurance Coverage | 1 | 2013 | 248 | 0.080 |
Why?
| | Sirolimus | 1 | 2013 | 282 | 0.080 |
Why?
| | Anxiety | 1 | 2019 | 1125 | 0.080 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2012 | 222 | 0.080 |
Why?
| | Fatal Outcome | 1 | 2012 | 302 | 0.080 |
Why?
| | Peroxides | 1 | 2010 | 18 | 0.080 |
Why?
| | Blood Flow Velocity | 2 | 2024 | 419 | 0.080 |
Why?
| | Esophagectomy | 1 | 2012 | 136 | 0.080 |
Why?
| | Linear Models | 1 | 2013 | 857 | 0.080 |
Why?
| | Logistic Models | 2 | 2013 | 2126 | 0.080 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 179 | 0.080 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 343 | 0.080 |
Why?
| | Medicare | 2 | 2013 | 920 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2013 | 455 | 0.070 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 236 | 0.070 |
Why?
| | Systole | 2 | 2020 | 179 | 0.070 |
Why?
| | Cattle | 1 | 2012 | 940 | 0.070 |
Why?
| | Radiography | 1 | 2012 | 861 | 0.070 |
Why?
| | Health Care Costs | 1 | 2012 | 423 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1543 | 0.070 |
Why?
| | Heart Valve Diseases | 1 | 2010 | 151 | 0.070 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2011 | 188 | 0.070 |
Why?
| | Prospective Studies | 2 | 2018 | 8123 | 0.070 |
Why?
| | Medicaid | 1 | 2013 | 477 | 0.070 |
Why?
| | Intensive Care Units | 1 | 2014 | 925 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1503 | 0.060 |
Why?
| | Stroke Volume | 2 | 2020 | 652 | 0.060 |
Why?
| | Databases, Factual | 1 | 2013 | 1493 | 0.060 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 517 | 0.060 |
Why?
| | Ligands | 2 | 2023 | 678 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3926 | 0.060 |
Why?
| | Perfusion Imaging | 1 | 2024 | 66 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2023 | 4118 | 0.050 |
Why?
| | Organ Specificity | 1 | 2025 | 307 | 0.050 |
Why?
| | Prognosis | 1 | 2012 | 4351 | 0.050 |
Why?
| | Surgery, Computer-Assisted | 1 | 2024 | 87 | 0.050 |
Why?
| | Printing, Three-Dimensional | 1 | 2024 | 102 | 0.050 |
Why?
| | Pulmonary Veins | 1 | 2024 | 110 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 376 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 162 | 0.050 |
Why?
| | Virginia | 2 | 2014 | 57 | 0.050 |
Why?
| | Magnetic Resonance Angiography | 1 | 2024 | 249 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2010 | 866 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 123 | 0.040 |
Why?
| | Swine | 1 | 2025 | 821 | 0.040 |
Why?
| | Pulmonary Circulation | 1 | 2024 | 431 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2023 | 158 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 330 | 0.040 |
Why?
| | Neurons | 1 | 2010 | 1668 | 0.040 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 12 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 370 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2786 | 0.040 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 39 | 0.040 |
Why?
| | Tobacco Use | 1 | 2021 | 67 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 46 | 0.040 |
Why?
| | Computer Simulation | 1 | 2024 | 1014 | 0.040 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2020 | 50 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 198 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 151 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2021 | 507 | 0.030 |
Why?
| | Blotting, Western | 1 | 2021 | 1177 | 0.030 |
Why?
| | Signal Transduction | 2 | 2023 | 5246 | 0.030 |
Why?
| | Myocardium | 1 | 2023 | 948 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1792 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1888 | 0.030 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 283 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2024 | 1982 | 0.030 |
Why?
| | Liver | 1 | 2025 | 1864 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 2012 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 930 | 0.030 |
Why?
| | RNA | 1 | 2021 | 926 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 3017 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 85 | 0.020 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 91 | 0.020 |
Why?
| | Citrates | 1 | 2012 | 41 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 64 | 0.020 |
Why?
| | Organ Preservation Solutions | 1 | 2012 | 47 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 87 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.020 |
Why?
| | Cold Ischemia | 1 | 2012 | 39 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 416 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 130 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 268 | 0.020 |
Why?
| | Reoperation | 1 | 2014 | 645 | 0.020 |
Why?
| | Cold Temperature | 1 | 2012 | 208 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 248 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2012 | 543 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 397 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1244 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2012 | 358 | 0.020 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2010 | 155 | 0.020 |
Why?
| | Vasoconstrictor Agents | 1 | 2010 | 148 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 640 | 0.020 |
Why?
| | Risk | 1 | 2012 | 920 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 508 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1378 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1298 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7230 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2010 | 337 | 0.020 |
Why?
| | Tissue Donors | 1 | 2012 | 425 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 216 | 0.020 |
Why?
| | Cell Movement | 1 | 2013 | 951 | 0.020 |
Why?
| | Heart Arrest | 1 | 2012 | 411 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 1077 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 396 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1224 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2012 | 1135 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6073 | 0.020 |
Why?
| | Contrast Media | 1 | 2010 | 493 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1331 | 0.020 |
Why?
| | Homeostasis | 1 | 2010 | 646 | 0.020 |
Why?
| | Genomics | 1 | 2010 | 853 | 0.010 |
Why?
| | Calcium | 1 | 2010 | 1181 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2010 | 1369 | 0.010 |
Why?
| | Proteomics | 1 | 2010 | 1203 | 0.010 |
Why?
| | Models, Biological | 1 | 2010 | 1761 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3545 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1996 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8391 | 0.010 |
Why?
|
|
Stone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|